DK3311823T3 - Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger - Google Patents

Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger Download PDF

Info

Publication number
DK3311823T3
DK3311823T3 DK17182792.6T DK17182792T DK3311823T3 DK 3311823 T3 DK3311823 T3 DK 3311823T3 DK 17182792 T DK17182792 T DK 17182792T DK 3311823 T3 DK3311823 T3 DK 3311823T3
Authority
DK
Denmark
Prior art keywords
compositions
methods
chitosan derivative
biofilm
breaking
Prior art date
Application number
DK17182792.6T
Other languages
English (en)
Inventor
Shenda Baker
William P Wiesmann
Stacy Townsend
Original Assignee
Synedgen Inc
Shenda Baker
William P Wiesmann
Stacy Townsend
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synedgen Inc, Shenda Baker, William P Wiesmann, Stacy Townsend filed Critical Synedgen Inc
Application granted granted Critical
Publication of DK3311823T3 publication Critical patent/DK3311823T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK17182792.6T 2009-09-02 2010-09-02 Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger DK3311823T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23918009P 2009-09-02 2009-09-02
EP10814536.8A EP2473042B1 (en) 2009-09-02 2010-09-02 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds

Publications (1)

Publication Number Publication Date
DK3311823T3 true DK3311823T3 (da) 2021-03-01

Family

ID=43649657

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17182792.6T DK3311823T3 (da) 2009-09-02 2010-09-02 Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger

Country Status (6)

Country Link
US (4) US20120329751A1 (da)
EP (2) EP2473042B1 (da)
AU (1) AU2010289417B2 (da)
CA (2) CA3004707C (da)
DK (1) DK3311823T3 (da)
WO (1) WO2011028967A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2848648C (en) 2006-06-02 2017-10-10 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
JP5530934B2 (ja) 2008-01-24 2014-06-25 ユニバーシティ オブ ユタ リサーチ ファンデーション 接着複合コアセルベートならびにその作製および使用方法
US8283384B2 (en) 2008-01-24 2012-10-09 University Of Utah Research Foundation Adhesive complex coacervates and methods of making and using thereof
EP2473042B1 (en) 2009-09-02 2017-08-02 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
US9439925B2 (en) 2010-04-06 2016-09-13 Synedgen, Inc. Methods and compositions for treating wounds utilizing chitosan compounds
EP2575906B1 (en) 2010-05-24 2014-12-10 University of Utah Research Foundation Reinforced adhesive complex coacervates and methods of making and using thereof
CA2812599A1 (en) 2010-11-12 2012-05-18 University Of Utah Research Foundation Simple adhesive coacervates and methods of making and using thereof
US20140221308A1 (en) * 2011-07-01 2014-08-07 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
WO2013126550A2 (en) * 2012-02-22 2013-08-29 Kci Licensing, Inc. New compositions, the preparation and use thereof
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
KR101926871B1 (ko) 2012-10-11 2018-12-07 부경대학교 산학협력단 인체면역결핍바이러스의 예방 또는 치료용 약제학적 조성물
US10077324B2 (en) 2013-02-06 2018-09-18 Kci Licensing, Inc. Polymers, preparation and use thereof
EP2968080B1 (en) * 2013-03-12 2023-05-10 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
WO2015082965A2 (en) * 2013-12-04 2015-06-11 Melder C Patrick Novel chitosan nasal wash
WO2016011028A1 (en) 2014-07-14 2016-01-21 University Of Utah Research Foundation In situ solidifying complex coacervates and methods of making and using thereof
CA2960998A1 (en) * 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
CA2988579A1 (en) * 2015-04-21 2016-10-27 Epibiome, Inc. Compositions and methods for increasing the susceptibility of bacteria to antibiotics
WO2017161113A1 (en) 2016-03-16 2017-09-21 Synedgen, Inc. Compositions and methods of their use
WO2019147922A2 (en) 2018-01-26 2019-08-01 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
AU2020444897A1 (en) * 2020-04-30 2022-12-08 Synedgen, Inc. Compositions and methods of use thereof
EP3973934B1 (en) * 2020-09-25 2023-12-20 Cobatt Polycationic polymer, composition comprising the polycationic polymer, and product, comprising an active surface, provided with the polycationic polymer
US20230381217A1 (en) * 2020-10-14 2023-11-30 Medoderm Gmbh Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease
IT202100010187A1 (it) * 2021-04-22 2022-10-22 Jointherapeutics S R L Uso di chitosano funzionalizzato nel trattamento di patologie infiammatorio-fibrotiche del tratto respiratorio e epatiche
US11546398B1 (en) 2022-03-09 2023-01-03 Cisco Technology, Inc. Real-time transport (RTC) with low latency and high scalability

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436950B1 (en) 1998-08-14 2002-08-20 Nastech Pharmaceutical Company, Inc. Nasal delivery of apomorphine
EP2258183A1 (en) 1998-12-22 2010-12-08 The University of North Carolina at Chapel Hill Compounds and uses for the treatment of airway diseases and for the delivery of airway drugs
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
US20030087414A1 (en) 2001-11-02 2003-05-08 Aerts Johannes Maria Franciscus Gerardus Mammalian mucinase, its recombinant production, and its use in therapy or prophylaxis against diseases in which mucus is involved or infectious diseases
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
GB0300597D0 (en) * 2003-01-10 2003-02-12 Microbiological Res Authority Phage biofilms
EP3192872A1 (en) 2003-08-26 2017-07-19 The Regents of the University of Colorado, a body corporate Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20100015061A1 (en) 2006-01-06 2010-01-21 Boehringer Ingeheim International GmnH Pharmaceutical Compositions Based on Anticholinergics and Andolast
CA2848648C (en) 2006-06-02 2017-10-10 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
WO2008049842A2 (en) 2006-10-26 2008-05-02 Boehringer Ingelheim International Gmbh Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP2121026B1 (en) 2006-12-11 2017-06-28 CHIT2GEL Ltd. Novel injectable chitosan mixtures forming hydrogels
WO2010021930A1 (en) * 2008-08-16 2010-02-25 Synedgen, Inc. Prevention and treatment of mrsa infections with chitosan-derivatives
AU2009313998B2 (en) 2008-11-12 2016-06-16 Synedgen, Inc. Chitosan derivatives to treat animals or optimize animal health
AU2009313937B2 (en) * 2008-11-12 2014-11-13 Synedgen, Inc. Chitosan derivatives alone or in combination for the treatment of MDR microbial infections
EP2391387A1 (en) 2009-01-29 2011-12-07 Synedgen, Inc. Nucleic acid delivery using modified chitosans
EP2473043B1 (en) 2009-09-02 2020-03-25 Synedgen, Inc. Oral care methods and compositions utilizing chitosan-derivative compounds
EP2473042B1 (en) 2009-09-02 2017-08-02 Synedgen, Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
PL3501499T3 (pl) 2010-02-11 2023-01-09 Ablynx Nv Sposoby i kompozycje do wytwarzania aerozoli
US9439925B2 (en) 2010-04-06 2016-09-13 Synedgen, Inc. Methods and compositions for treating wounds utilizing chitosan compounds
US20140221308A1 (en) 2011-07-01 2014-08-07 Synedgen, Inc. Methods and compositions of reducing and preventing bacterial growth and the formation of biofilm on a surface utilizing chitosan-derivative compounds
US20150031610A1 (en) 2012-03-05 2015-01-29 Synedgen, Inc. Derivatized polyglucosamines for delivery of small molecules, peptides, and proteins
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
EP2968080B1 (en) 2013-03-12 2023-05-10 Synedgen, Inc. Oral formulation of polyglucosamine derivatives in combination with a non-fermentable sugar
US11433092B2 (en) 2013-03-15 2022-09-06 Synedgen, Inc. Compositions and methods of use for wound healing
JP6300360B2 (ja) 2013-05-27 2018-03-28 大阪エヌ・イー・ディー・マシナリー株式会社 球体回転機構及び球体表面検査装置
CA2960998A1 (en) 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
CA2982259A1 (en) 2015-04-22 2016-10-27 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating mycobacteria infections and lung disease
AU2020444897A1 (en) 2020-04-30 2022-12-08 Synedgen, Inc. Compositions and methods of use thereof
US11390408B2 (en) 2020-11-24 2022-07-19 Axon Llc System and method for applying tubular bands to containers utilizing angled band ejection

Also Published As

Publication number Publication date
EP2473042A1 (en) 2012-07-11
WO2011028967A1 (en) 2011-03-10
US20120329751A1 (en) 2012-12-27
AU2010289417B2 (en) 2015-08-13
US20240197768A1 (en) 2024-06-20
US20200009182A1 (en) 2020-01-09
CA3004707C (en) 2022-05-31
CA3004707A1 (en) 2011-03-10
CA2806559A1 (en) 2011-03-10
EP3311823A1 (en) 2018-04-25
CA2806559C (en) 2018-06-26
EP2473042A4 (en) 2013-05-22
EP3311823B1 (en) 2020-11-25
AU2010289417A1 (en) 2012-04-26
US11786547B2 (en) 2023-10-17
EP2473042B1 (en) 2017-08-02
US20170136056A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
DK3311823T3 (da) Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger
LTC2937418I2 (lt) Kompozicijos ir būdas transtiretino raiškos slopinimui
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
FR2941462B1 (fr) Composition decapante
DK3812360T3 (da) Monochlortrifluorpropen forbindelser og sammensætninger og metoder, der anvender dem
DK2323638T3 (da) Sammensætninger og fremgangsmåder til behandling af osteoartritis
DK2565193T3 (da) Sammensætninger og fremgangsmåder til hæmning af JAK-signalvejen
BRPI0922084A2 (pt) Composições e métodos compreendendo variantes de serina protease
DK2894165T3 (da) Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
DK2271642T3 (da) Pyridylinhibitorer af hedgehog signalering
IT1400768B1 (it) Componente micromeccanico
DK3252057T3 (da) Multicykliske forbindelser og fremgangsmåder til anvendelse deraf
BR112012000525A2 (pt) inibidores da bace
DK3128014T3 (da) Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger
UY33161A (es) Composiciones plaguicidas
DK2361090T3 (da) Sammensætninger til behandling af centralt medieret kvalme og opkastning
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
BR112012005321A2 (pt) processo e composição
BRPI0908547A2 (pt) aparelho comutador
DK2446246T3 (da) Indretning og fremgangsmåde til udvælgelse af partikler
BRPI1010690A2 (pt) composições
DK3263112T3 (da) Sammensætninger og fremgangsmåder til undertrykkelse af endometriproliferationer
DK2442832T3 (da) Sammensætninger og fremgangsmåder til behandling af dissemineret sclerose